Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filings

Filing date Description Form Filing Group View
D
Other
View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Data provided by Kaleidoscope.